Robert A. Hodgson

3.1k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Robert A. Hodgson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Robert A. Hodgson has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 9 papers in Physiology. Recurrent topics in Robert A. Hodgson's work include Receptor Mechanisms and Signaling (14 papers), Adenosine and Purinergic Signaling (9 papers) and Neuroendocrine regulation and behavior (6 papers). Robert A. Hodgson is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Adenosine and Purinergic Signaling (9 papers) and Neuroendocrine regulation and behavior (6 papers). Robert A. Hodgson collaborates with scholars based in United States, Canada and United Kingdom. Robert A. Hodgson's co-authors include Geoffrey B. Varty, Annamarie J. Pond, Eric M. Parker, Anjli Venkateswaran, Judith Frydman, Antti Nurmi, Ron R. Kopito, Alexander McCampbell, Gabrielle G. Leblanc and Marc Baumann and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Robert A. Hodgson

41 papers receiving 1.7k citations

Hit Papers

Protein misfolding in neurodegenerative diseases: implica... 2017 2026 2020 2023 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Protein misfolding in neurodegenerative diseases: implications and strategies
    2017 462 citations Anjli Venkateswaran, Robert A. Hodgson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Hodgson United States 21 698 586 279 226 225 42 1.8k
Maria Lindskog Sweden 26 1.2k 1.7× 1.5k 2.6× 470 1.7× 203 0.9× 188 0.8× 51 3.0k
Alicia Rivera Spain 27 1.2k 1.8× 1.7k 2.8× 274 1.0× 337 1.5× 224 1.0× 54 2.6k
Leonard P. Miller United States 27 781 1.1× 1.3k 2.2× 360 1.3× 320 1.4× 156 0.7× 54 2.5k
Manuela Marcoli Italy 29 1.1k 1.6× 1.2k 2.0× 272 1.0× 142 0.6× 339 1.5× 114 2.4k
Robert F. Berman United States 28 400 0.6× 972 1.7× 126 0.5× 142 0.6× 352 1.6× 54 1.9k
Marc De Ryck Belgium 21 452 0.6× 773 1.3× 174 0.6× 296 1.3× 56 0.2× 39 1.7k
Ronald F. Mervis United States 23 631 0.9× 789 1.3× 637 2.3× 127 0.6× 47 0.2× 47 2.7k
Sarah Bailey United Kingdom 24 727 1.0× 456 0.8× 217 0.8× 40 0.2× 258 1.1× 55 1.6k
Ken Nakazawa Japan 31 1.2k 1.7× 1.0k 1.8× 286 1.0× 191 0.8× 835 3.7× 135 2.8k
Sung Won Kim United States 21 678 1.0× 368 0.6× 266 1.0× 154 0.7× 55 0.2× 51 1.9k

Countries citing papers authored by Robert A. Hodgson

Since Specialization
Citations

This map shows the geographic impact of Robert A. Hodgson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Hodgson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Hodgson more than expected).

Fields of papers citing papers by Robert A. Hodgson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Hodgson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Hodgson. The network helps show where Robert A. Hodgson may publish in the future.

Co-authorship network of co-authors of Robert A. Hodgson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Hodgson. A scholar is included among the top collaborators of Robert A. Hodgson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Hodgson. Robert A. Hodgson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodgson, Robert A., Brian K. Kennedy, Eliezer Masliah, et al.. (2019). Aging: therapeutics for a healthy future. Neuroscience & Biobehavioral Reviews. 108. 453–458. 20 indexed citations
2.
Aslanian, Robert, Tanweer A. Khan, Rongze Kuang, et al.. (2015). Discovery of aminoquinazoline derivatives as human A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 26(4). 1348–1354. 7 indexed citations
3.
Hodgson, Robert A., Deborra Mullins, Sherry Lu, et al.. (2014). Characterization of a novel vasopressin V1b receptor antagonist, V1B-30N, in animal models of anxiety-like and depression-like behavior. European Journal of Pharmacology. 730. 157–163. 25 indexed citations
4.
Kazdoba, Tatiana M., et al.. (2013). Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model. Pharmacology Biochemistry and Behavior. 118. 36–45. 9 indexed citations
5.
Fox, Steven V., Anthony L. Gotter, Spencer J. Tye, et al.. (2013). Quantitative Electroencephalography Within Sleep/Wake States Differentiates GABAA Modulators Eszopiclone and Zolpidem From Dual Orexin Receptor Antagonists in Rats. Neuropsychopharmacology. 38(12). 2401–2408. 33 indexed citations
6.
Jones, Nicole M., et al.. (2013). A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats. Brain Research Bulletin. 98. 163–169. 20 indexed citations
7.
Ho, Ginny D., W. Michael Seganish, Deen Tulshian, et al.. (2012). The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(7). 2585–2589. 20 indexed citations
8.
Ho, Ginny D., Shu‐Wei Yang, Terry L. Nechuta, et al.. (2011). The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(2). 1019–1022. 28 indexed citations
9.
Hodgson, Robert A., Paul J. Bédard, Geoffrey B. Varty, et al.. (2010). Preladenant, a selective A2A receptor antagonist, is active in primate models of movement disorders. Experimental Neurology. 225(2). 384–390. 78 indexed citations
10.
Hodgson, Robert A., Lynn A. Hyde, Mary Cohen-Williams, et al.. (2010). Characterization of the selective mGluR1 antagonist, JNJ16259685, in rodent models of movement and coordination. Pharmacology Biochemistry and Behavior. 98(2). 181–187. 13 indexed citations
11.
Anderson, Kym, Orley Ashenfelter, Victor Ginsburgh, et al.. (2009). JWE volume 4 issue 2 Cover and Front matter. Journal of Wine Economics. 4(2). f1–f4. 1 indexed citations
12.
13.
Scott, Jack D., Michael W. Miller, Sue‐Ing Lin, et al.. (2009). Tetrahydroquinoline sulfonamides as vasopressin 1b receptor anatgonists. Bioorganic & Medicinal Chemistry Letters. 19(21). 6018–6022. 14 indexed citations
14.
Varty, Geoffrey B., et al.. (2008). The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates. Psychopharmacology. 200(3). 393–401. 40 indexed citations
15.
Varty, Geoffrey B., Sherry Lu, Cynthia A. Morgan, et al.. (2008). The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510). Journal of Pharmacology and Experimental Therapeutics. 326(2). 672–682. 67 indexed citations
16.
Mullins, Deborra, Cliona MacSweeney, Barbara Werner, et al.. (2008). Characterization of the V1a antagonist, JNJ-17308616, in rodent models of anxiety-like behavior. Psychopharmacology. 202(4). 711–718. 57 indexed citations
17.
Hodgson, Robert A., David Guthrie, & Geoffrey B. Varty. (2007). Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: Sensitivity to anxiolytic and antidepressant drugs. Pharmacology Biochemistry and Behavior. 88(3). 341–348. 50 indexed citations
18.
19.
Hodgson, Robert A., et al.. (2004). Training-induced and electrically induced potentiation in the neocortex. Neurobiology of Learning and Memory. 83(1). 22–32. 53 indexed citations
20.
Hodgson, Robert A., et al.. (1995). Of Kiosks and Campuses. T.H.E. Journal Technological Horizons in Education. 23(1). 69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Lindskog Breakdown of academic impact, for papers by Alicia Rivera Breakdown of academic impact, for papers by Leonard P. Miller Breakdown of academic impact, for papers by Manuela Marcoli Breakdown of academic impact, for papers by Robert F. Berman Breakdown of academic impact, for papers by Marc De Ryck Breakdown of academic impact, for papers by Ronald F. Mervis Breakdown of academic impact, for papers by Sarah Bailey Breakdown of academic impact, for papers by Ken Nakazawa Breakdown of academic impact, for papers by Sung Won Kim
Rankless by CCL
2026